Progesterone < Prognosis < Program Evaluation

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 101.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000341 (2013)		Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosis.
000A92 (2013)		Utility of ¹¹¹indium-pentetreotide scintigraphy in patients with neuroendocrine tumors.
000B82 (2012)		Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
000D25 (2012)		Gallium-68 somatostatin receptor PET/CT: is it time to replace (111)Indium DTPA octreotide for patients with neuroendocrine tumors?
000E51 (2012)		Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).
001017 (????)		Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?
001090 (2011)		Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507.
001102 (2012)		Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients.
001136 (2011)		The scintigraphic index spleen/liver at 30 minutes predicts the success of splenectomy in persistent and chronic primary immune thrombocytopenia.
001473 (2011)		Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by ¹¹¹Indium-octreotide imaging.
001744 (2010)		Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry.
001816 (2010)		A pretherapy biodistribution and dosimetry study of indium-111-radiolabeled trastuzumab in patients with human epidermal growth factor receptor 2-overexpressing breast cancer.
001817 (2010)		Predictors of survival in idiopathic interstitial pneumonia.
001A61 (????)		111-In-capromab pendetide imaging using hybrid-γ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer.
001E35 (????)		Metabolic and receptor imaging in patients with neuroendocrine tumors: comparison of fludeoxyglucose-positron emission tomography and computed tomography with indium in 111 pentetreotide.
001F71 (2009)		[PET-CT for neuroendocrine tumors and nuclear medicine therapy options].
002111 (2009)		First report on a prospective trial with yttrium-90-labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma.
002162 (2009)		Octreotide uptake in intracranial metastasis of pancreatic ductal adenocarcinoma origin in a patient with a prolonged clinical course.
002365 (2008)		Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
002491 (2008)		Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.
002492 (2008)		Indium-111 capromab pendetide in the management of recurrent prostate cancer.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Prognosis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Prognosis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Prognosis
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024